Protocols – essentially the blueprints for clinical trials – are typically kept under wraps until studies are complete, but Pfizer and Moderna have made the ones for their SARS-CoV-2 trials public in a transparency push.

LEAVE A REPLY

Please enter your comment!
Please enter your name here